LABORATORY FOR CARDIOVASCULAR BIOENGINEERING & THERAPEUTICS

Loading
Dr. Baker

Dr. Baker specializes in cardiovascular biology—specifically devices and interventional technologies to prevent atherosclerosis and restenosis. His research focuses on vascular mechanotransduction, or the study of cell and tissue responses to mechanical forces. Additionally, his lab works to advance vascular drug delivery and testing of drugs to be used for vessel regrowth and heart revascularization.

IN THE NEWS

  • May 2013: Gunjan Singh receives Unrestricted Endowed Presidential Scholarship!

  • May 2013: Jason Lee and Anthony Monteforte pass their Qualification Exam!

  • May 2013: Collin Johnson receives Health Sciences Fellowship ($4000) from SouthWest Affiliate Research Committee of the American Heart Association (AHA) for this summer!

  • April 2013: Gunjan Singh won the first prize ($300) in the Intellectual Entrepreneurship Pre–Graduate School Internship Poster Competition!

  • March 2013: Collin Johnson abstract "Heparanase Alters Endothelial Phenotype, Leukocyte Attachment and Atherosclerotic Plaque Formation" gets accepted for the American Heart Association ATVB 2013 Conference at Orlando!

  • More news...

RESEARCH AREAS

  • Research

    Vascular Biology

    Our laboratory seeks to better understand the basic pathophysiologic processes that underlie atherosclerosis, stroke and other vascular disorders.

  • Research

    Therapeutics for Peripheral and Myocardial Ischemia

    Our laboratory seeks to understand why growth factor based therapies have failed to treat ischemia in patients and seeks to create novel therapeutics to increase growth factor effectiveness in this context.

  • ResearchMechanobiology

    Our lab is developing novel devices and molecular techniques for studying how vascular cells sense and respond to mechanical forces.

  • Research

    Implanted Cardiovascular Devices

    Our group works to understand the fundamental mechanisms that control the biological response to cardiovascular devices such as endovascular stents with the ultimate goal of designing more effective interventions for cardiovascular disease.